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Introduction: Supratentorial primitive neuroectodermal tumors predominantly occur in children, and are rare in the
adult population. Less than 100 cases of supratentorial primitive neuroectodermal tumor have been reported in
adults internationally. Our case study reports this rare incident.
Case presentation: A 22-year-old Hispanic man presented with headaches, blurry vision, diplopia, intermittent
vomiting, and grossly decreased vision. A magnetic resonance image showed a left posterior parietal
heterogeneously enhancing mass measuring 4.2cm × 7.2cm × 7.0cm. After craniotomy for resection and
decompression, the mass was histologically revealed to be a supratentorial primitive neuroectodermal tumor.
Standardized immunohistochemical studies for this mass were carried out.
Conclusion: We have concluded that immunohistochemical and genetic workup should be included in the
standardized pathological workup for primitive neuroectodermal tumors in order to provide more prognostic
information. Based on our current literature review, we propose an immunohistochemical panel.Introduction
Supratentorial primitive neuroectodermal tumors (sPNETs)
are known to be tumors of the pediatric population.
According to the World Health Organization, sPNETs
are described as a cerebral or suprasellar embryonal grade
IV tumor made up of undifferentiated or poorly differen-
tiated neuro-epithelial cells which have the capacity for,
or display, divergent differentiation along neuronal, as-
trocytic, ependymal, muscular or melanocytic lines. Ap-
proximately 1% of pediatric brain tumors are sPNETs.
However, they can sporadically occur in adults. To date,
only less than 100 sPNET cases have been reported in
adult patients [1].
In an extensive case review series by Ohba et al., it
was determined that the mean age of diagnosis in adults
was 35.2 years of age, with one peak between the ages of* Correspondence: ohaririucla@gmail.com
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reproduction in any medium, provided the orthe second and third decades. Throughout all age groups,
more males were prone to be diagnosed with pNETS than
females [1].
Of the PNETs in the central nervous system (CNS)
5.6% are supratentorial. Moreover, the locations of these
tumors are almost equally distributed in the frontal,
temporal, and parietal lobes [1]. Less than 50% of these
patients have a survival rate of 5 years post-diagnosis
[2]. Radiographically, the best diagnostic clue is the pre-
sence of a large, complex hemispheric mass with minimal
peritumor vasogenic edema. Cerebral hemispheric PNETs
have a mean diameter of approximately 5cm at diagnosis.
PNETs often appear with necrosis, intra-tumor hemor-
rhage, cysts, and calcification (50–70%). On computed
tomography, these lesions appear as isodense or hyper-
dense. On magnetic resonance imaging (MRI), these
tumors appear as well-delimited, inhomogeneous, and
variably contrast-enhanced lesions. Furthermore, on T1-
weighted images, PNETs appear hypointense, and on T2-
weighted images they appear hyperintense [3-6].
Histologically, the highly cellular tumor consists of
anaplastic cells with small round to oval hyperchromatical Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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review of the literature, we propose a novel pathological
and genetic panel workup for brain masses in adults that
are suspected to be PNETs based on radiographic studies
and intra-operative pathological diagnosis.
Case presentation
A 22-year-old Hispanic man was referred to a neurosur-
gery clinic by his ophthalmologist, who was concerned
about increased intracranial pressure after noticing pa-
pilledema on fundoscopic examination. The patient had
been complaining of headaches, blurry vision, diplopia,
and intermittent vomiting for a month. He reported that
his symptoms had been worsening over the past week.
The patient has no other significant past medical history
and has been in general good health besides the recent
onset of headaches. He was a resident of California. Fur-
thermore, on physical examination, left horizontal nys-
tagmus and grossly decreased vision on the right temporal
and right nasal hemifield were noticed.Figure 1 Histopathology. Photomicrographs of tumor showing
small, round, and undifferentiated cells with scant cytoplasm and
round or oval nuclei with dense chromatin or prominent nucleoli,
forming structures reminiscent of Homer-Wright rosettes
(black arrowheads), as well as mitosis.A brain MRI revealed a left posterior parietal, irregu-
lar, hemorrhagic mass measuring approximately 4.2cm ×
7.2cm × 7.0cm, enhancing heterogeneously, and asso-
ciated surrounding vasogenic edema and a 8.7mm mid-
line shift from left to right. Compressions of the atrium
of the left lateral ventricle, and the third ventricle, as
well as some effacement of the quadrigeminal plate cis-
tern, particularly on the left were noted (Figure 2).
The patient underwent a left parieto-occipital cranio-
tomy with resection, and the ultimate goal of debulking
of mass. Intra-operatively, the lesion was noted to have a
necrotic center. Initially, a fresh frozen specimen showed
the tumor to be glioblastoma multiforme. However, a
studied permanent specimen indicated a primitive neu-
roectodermal tumor with 5 to 10 mitoses per high-power
field. There were many cells immunoreactive to neuron-
specific enolase, CD56, and small cell neuroendocrine car-
cinoma. However, none were immune-reactive to synapto-
physin or glial fibrillary acidic protein. There were no
intra-operative or postoperative complications.
Discussion
Therapeutic approaches are close to non-existent because
the pathological mechanisms underlying sPNETs are
poorly understood. Some of the proposed genetic altera-
tions include: isochromosome 17q; losses of chromosomesFigure 2 Magnetic resonance image of mass. A: Flair showing
mild peritumoral edema, B: T1-weighted image without contrast, C:
T1-weighted image with contrast showing homogenous
enhancement, D: Gradient echo.
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TP53. PNETs are classified into peripheral and central.
Intracranial peripheral PNET has a better prognosis in
comparison to central PNET. Accordingly, it is essential
to differentiate between the two types. Chromosomal
translocation of chromosome (11;22) is phenomenal in
that it is unique to central and not peripheral PNETs.
Thus, the usage of immunohistochemical assay for CD99
and fluorescence in situ hybridization (FISH) assay for the
(11;22) translocation have granted the capability to distin-
guish between intracranial peripheral and intracranial cen-
tral PNET [1,7]. More importantly, in a study by Hayden
et al., it has been suggested that mutations in IDH1, which
encodes for cytoplasmic isocitrate dehydrogenase, are
among the most frequent mutations in sPNET, and are
much more prevalent in adult cases in comparison to
pediatric cases [8]. Furthermore, Gessi et al. have shown
that a high incidence of TP53 mutations and the absence
of amplification of the c-myc/N-myc genes in adult
sPNET, in comparison to pediatric PNET, suggest that
adult sPNET should be an independent subset of tumors
among CNS-PNETs [3].
Even though no prospective treatment studies have been
conducted to date, and no optimal treatment regimen for
sPNET has been established, a complete surgical excision
followed by radiation therapy has been proved to be cru-
cial in many retrospective studies [9-12]. Radiotherapy to
the entire neuroaxis is recommended because cerebro-
spinal dissemination at the time of diagnosis was found in
almost 10% of all cases.
Conclusion
An extensive review of the current literature suggests that
immunohistochemical and genetic assays are becoming
essential markers for prognosis and possible treatment of
sPNETs. As we discover more about all the mentioned
studies, it will become essential to integrate them into our
standard pathological workup for brain masses in adults
that are highly suspicious to be PNETs based on radio-
graphic studies and preliminary intra-operative patholo-
gical diagnosis.
We propose immunohistochemical and genetic assays
panels, which to the best of our knowledge has not been
proposed in the literature before, and we have decided
to use this panel in our institutions. We believe that ini-
tially a genetic assay should evaluate any potential mu-
tations to IDH1 (more prevalent in adult cases) to
differentiate adult sPNET from other possible pediatric
PNETs. Furthermore, an evaluation of TP53 mutations
(high incidents in adults) and c-myc/N-myc genes (absence
of amplification in adults) should be evaluated in order
to differentiate between a true sPNET and any pediatric
PNETs. Subsequently, a CD99 and a FISH assay for the
(11;22) translocation (phenomenal in that it is unique tocentral and not peripheral PNETs) should be conducted in
order to distinguish between intracranial peripheral and
intracranial central PNETs, because the prognosis of cen-
tral and peripheral PNETs are drastically different, as men-
tioned previously.Consent
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